Healthtech Investors & VC Firms in France
104 firms in this list, with a median first check of $1M. 30 of them lead rounds. Generated from verified public data and updated continuously.
BioMedPartners
BaselSeed–Late Stage$648K – $6.5M
28 people
Equistone Partners Europe
Growth$27M – $216M
Matterwave Ventures
MunichSeed–Series B$1.1M – $10.8M
15 people
Panacea Venture
SingaporePre-Seed–Late Stage
20 people
AdBio partners
ParisPre-Seed–Series A
21 people
EMZ Partners
Paris$16M – $160M
30 people
Btomorrow Ventures
LondonSeed–Growth
21 people
Citizen Capital
ParisSeed–Late Stage$3M – $10.8M
25 people
Gilde Healthcare
UtrechtSeed–Late Stage$1.1M – $55M
24 people
Forepont Capital Partners
New YorkPre-Seed–Late Stage
24 people
Fly Ventures
BerlinPre-Seed–Series A$1.1M – $4.3M
8 people
TVM Capital
MunichSeed–Late Stage$1.1M – $16.2M
22 people
500 Startups
San FranciscoPre-Seed–Late Stage$10K – $250K
8 people
Agoranov
ParisPre-Seed–Seed
Privilège Ventures
LuganoPre-Seed–Series A$100K – $1M
15 people
Starquest Capital
ParisSeed–Growth$530K – $21.2M
14 people
Big Pi Ventures
AthensPre-Seed–Growth$540K – $3.2M
19 people
M80 Partners
BrusselsGrowth–Late Stage$11M – $66M
16 people
ISALT - Investissements Stratégiques en Actions Long Terme
Paris
23 people
Goodwater Capital
BurlingamePre-Seed–Late Stage$5M – $50M
10 people
Lauxera Capital Partners
ParisGrowth–Late Stage$22M – $110M
16 people
MSM
LisbonSeed–Series A
11 people
Quantonation
ParisPre-Seed–Series B
9 people
Invivo Capital Partners
BarcelonaPre-Seed–Series A$2.2M – $4.3M
11 people
Related lists
Investors & VC Firms in United States (5050)Crypto & Web3 Investors & VC Firms (4688)Investors & VC Firms in Global (4044)SaaS Investors & VC Firms (3602)AI & Machine Learning Investors & VC Firms (3577)Fintech Investors & VC Firms (3506)Healthtech Investors & VC Firms (3208)Enterprise Software Investors & VC Firms (3098)Investors & VC Firms in Europe (2833)Healthtech Seed Investors & VC Firms (2488)
Data sourced from public filings and firms' own websites — see our methodology.






































































